Announcements Trials

Browse Landscape

Phase

Status

Terminated 3 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Intraductal Neoplasms 1 Colorectal Neoplasms 1

Interventions

Bevacizumab 30 pembrolizumab 29 Oxaliplatin 28 Leucovorin 25 Fluorouracil 24 Irinotecan 22 Cetuximab 22 Capecitabine 19 Nivolumab 15 Specimen Handling 12 atezolizumab 11 Panitumumab 11 Colonoscopy 9 Carboplatin 9 regorafenib 8 Biopsy 8 trifluridine tipiracil drug combination 7 Trifluridine 7 Paclitaxel 7 Aspirin 7 balstilimab 6 Standard of Care 6 Cisplatin 6 tislelizumab 5 encorafenib 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Immunoglobulin G 5 Folfox protocol 5 Disulfides 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Colorectal Neoplasms × Sulindac × Clear all

NCT01349881 2026-04-02

PACES

SWOG Cancer Research Network

Phase 3 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡